Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Alexandra Smith, Ryunosuke Saiki et al.|Nature Medicine|2020Cited by 633
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Anthony M. Hunter et al.|Blood|2024Cited by 3
Artificial-Intelligence, Data-Driven, Comprehensive Classification of Myeloid Neoplasms Based on Genomic, Morphological and Histological FeaturesLuca Lanino, David Quintela, Saverio D’Amico et al.|Blood|2024Cited by 2
Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 PatientsLuca Lanino, Rami S. Komrokji, Michaëla Fontenay et al.|Blood|2023Cited by 1